Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 7LKP | P78363 | Structure of ATP-free human ABCA4 | |
| 7LKZ | P78363 | Structure of ATP-bound human ABCA4 | Retinal-specific phospholipid-transporting ATPase ABCA4 (E.C.7.6.2.1) |
| 7LL1 | Q2N0S6 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
| 7LL1 | Q2N0S7 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
| 7LL1 | 7LL1 | Cryo-EM structure of BG505 DS-SOSIP in complex with glycan276-dependent broadly neutralizing antibody VRC40.01 Fab | |
| 7LL2 | Q2N0S6 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
| 7LL2 | Q2N0S7 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
| 7LL2 | 7LL2 | Cryo-EM structure of BG505 DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody VRC33.01 Fab | |
| 7LLK | O55774 | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
| 7LLK | 7LLK | Cryo-EM structure of Q23.17_DS-SOSIP in complex with Glycan276-Dependent Broadly Neutralizing Antibody 179NC75 Fab | |
| 7LM8 | P0DTC2 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
| 7LM8 | 7LM8 | Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with two cross-neutralizing antibodies CV38-142 and COVA1-16 Fabs isolated from COVID-19 patients | |
| 7LM9 | D2E265 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
| 7LM9 | 7LM9 | Crystal structure of SARS-CoV spike protein receptor-binding domain in complex with a cross-neutralizing antibody CV38-142 Fab isolated from COVID-19 patient | |
| 7LO4 | Q9BYF1 | SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 | |
| 7LO4 | P0DTC2 | SARS-CoV-2 spike receptor-binding domain with a G485R mutation in complex with human ACE2 | |
| 7LO6 | Q2N0S6 | Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope glycoprotein gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, 17b Fab Light Chain, 17b Fab Heavy Chain |
| 7LO6 | 7LO6 | Structure of CD4 mimetic BNM-III-170 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope glycoprotein gp120, HIV-1 Envelope Glycoprotein BG505 SOSIP.664 gp41, 17b Fab Light Chain, 17b Fab Heavy Chain |
| 7LOK | Q2N0S6 | Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein BG505 SOSIP.664 gp120, 17b Fab Light Chain, 17b Fab Heavy Chain, M48U1 |
| 7LOK | 7LOK | Structure of CD4 mimetic M48U1 in complex with BG505 SOSIP.664 HIV-1 Env trimer and 17b Fab | Envelope Glycoprotein BG505 SOSIP.664 gp41, Envelope glycoprotein BG505 SOSIP.664 gp120, 17b Fab Light Chain, 17b Fab Heavy Chain, M48U1 |
| 7LOP | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022 | |
| 7LOP | 7LOP | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV05-163 and CR3022 | |
| 7LPN | Q2N0S6 | Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 | |
| 7LPN | 7LPN | Cryo-EM structure of llama J3 VHH antibody in complex with HIV-1 Env BG505 DS-SOSIP.664 | |
| 7LQ7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 | |
| 7LQ7 | 7LQ7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies CV503 and COVA1-16 | |
| 7LQJ | O67854 | Crystal structure of LeuT bound to L-Alanine | |
| 7LQK | O67854 | Crystal structure of the R375A mutant of LeuT | |
| 7LQL | O67854 | Crystal structure of the R375D mutant of LeuT | |
| 7LQV | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 4-8 Fab |
| 7LQV | 7LQV | Cryo-EM structure of NTD-directed neutralizing antibody 4-8 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 4-8 Fab |
| 7LQW | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 2-17 Fab |
| 7LQW | 7LQW | Cryo-EM structure of NTD-directed neutralizing antibody 2-17 Fab in complex with SARS-CoV-2 S2P spike | SARS-CoV-2 spike glycoprotein, neutralizing antibody 2-17 Fab |
| 7LR2 | C2GY91 | Crystal structure of GH5_18 from Bifidobacterium longum subsp. longum ATCC 55813 in complex with GlcNAc | |
| 7LR6 | C2GY91 | Crystal structure of GH5_18-E140A from Bifidobacterium longum subsp. longum ATCC 55813 in complex with Manb1-4GlcNAc | |
| 7LR7 | F8JJ04 | Crystal structure of GH5_18 from Streptomyces cattleya in complex with GlcNAc | |
| 7LR8 | F8JJ04 | Crystal structure of GH5_18-E153A from Streptomyces cattleya in complex with Manb1-4GlcNAc | |
| 7LRF | Q90922 | Netrin-1 in complex with SOS | |
| 7LRM | P03366 | Structure of HIV-1 Reverse Transcriptase in complex with DNA, dCTP, and CA(2+) ion | |
| 7LRS | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
| 7LRS | 7LRS | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
| 7LRT | P0DTC2 | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
| 7LRT | 7LRT | Cryo-EM structure of SARS-CoV-2 spike in complex with neutralizing antibody A23-58.1 that targets the receptor-binding domain | |
| 7LRX | P03366 | Structure of HIV-1 Reverse Transcriptase in complex with DNA, L-dCTP, and CA(2+) ion | |
| 7LRY | P03366 | Structure of HIV-1 Reverse Transcriptase in complex with DNA, (-)FTC-TP, and CA(2+) ion | |
| 7LS0 | Q6UX46 | Structure of the Human ALK GRD bound to AUG | |
| 7LS0 | Q9UM73 | Structure of the Human ALK GRD bound to AUG | |
| 7LS9 | P0DTC2 | Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7LS9 | 7LS9 | Cryo-EM structure of neutralizing antibody 1-57 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 7LSA | A0A2N0UU23 | Ruminococcus bromii Amy12 with maltoheptaose |
